triamterene has been researched along with perindopril in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bonney, MA; Celermajer, DS; McCredie, RJ; McFarlane, R; Molyneaux, L; Yue, DK; Zilkens, R | 1 |
Conway, EL; Dawson, M; Louis, WJ; Mander, AG; O'Callaghan, C | 1 |
1 review(s) available for triamterene and perindopril
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for triamterene and perindopril
Article | Year |
---|---|
Angiotensin converting enzyme inhibition and arterial endothelial function in adults with Type 1 diabetes mellitus.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diuretics; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hydrochlorothiazide; Indoles; Male; Perindopril; Triamterene | 1999 |
Use of computerized neuropsychological tests (CANTAB) to assess cognitive effects of antihypertensive drugs in the elderly. Cambridge Neuropsychological Test Automated Battery.
Topics: Aged; Aging; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cognition; Cross-Over Studies; Diagnosis, Computer-Assisted; Diuretics; Double-Blind Method; Drug Combinations; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Neuropsychological Tests; Perindopril; Triamterene | 1999 |
1 other study(ies) available for triamterene and perindopril
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |